{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T01:37:27Z","timestamp":1748482647027,"version":"3.32.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","surgjournal.com","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.surg.2024.10.017","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T01:40:18Z","timestamp":1732844418000},"page":"108926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of tumor-antigen signatures and immune subtypes for mRNA vaccine selection in muscle-invasive bladder cancer"],"prefix":"10.1016","volume":"178","author":[{"given":"Zhijie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghou","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiye","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2024.10.017_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.surg.2024.10.017_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib3","first-page":"44","article-title":"Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)","volume":"9","author":"Jin","year":"2022","journal-title":"Mil Med Res"},{"key":"10.1016\/j.surg.2024.10.017_bib4","first-page":"2158","article-title":"A\u00a0review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group","volume":"186","author":"Brausi","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.surg.2024.10.017_bib5","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.surg.2024.10.017_bib6","article-title":"A\u00a0novel DNA methylation signature as an independent prognostic factor in muscle-invasive bladder cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.annonc.2022.01.075","article-title":"Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Moschini","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib8","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2024.10.017_bib9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2024.10.017_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1470-2045(17)30065-7","article-title":"Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial","volume":"18","author":"Sharma","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1200\/JCO.2021.39.6_suppl.435","article-title":"Post-hoc analysis of long-term outcomes in patients with CR, PR, or SD to pembrolizumab (pembro) or platinum-based chemotherapy (chemo) as 1L therapy for advanced urothelial carcinoma (UC) in KEYNOTE-361","volume":"39","author":"Loriot","year":"2021","journal-title":"Am Soc Clin Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib12","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.18.01148","article-title":"Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study","volume":"36","author":"Necchi","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11523-020-00788-w","article-title":"Vaccine therapies for cancer: then and now","volume":"16","author":"Morse","year":"2021","journal-title":"Targ Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.surg.2024.10.017_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-023-01807-w","article-title":"The use of RNA-based treatments in the field of cancer immunotherapy","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.surg.2024.10.017_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-021-01348-0","article-title":"mRNA therapeutics in cancer immunotherapy","volume":"20","author":"Beck","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.surg.2024.10.017_bib17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.vaccine.2016.05.073","article-title":"Personalized cancer vaccines: targeting the cancer mutanome","volume":"35","author":"Zhang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.surg.2024.10.017_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.surg.2024.10.017_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112037","article-title":"The dawn of a new era: mRNA vaccines in colorectal cancer immunotherapy","volume":"132","author":"Song","year":"2024","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.surg.2024.10.017_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.surg.2024.10.017_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.surg.2024.10.017_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94729-w","article-title":"Oxidative stress parameters as biomarkers of bladder cancer development and progression","volume":"11","author":"Wigner","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.surg.2024.10.017_bib23","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s11033-021-06266-4","article-title":"Oxidative stress in bladder cancer: an ally or an enemy?","volume":"48","author":"Mendes","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.surg.2024.10.017_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00262-019-02443-4","article-title":"Mechanisms of immune evasion in bladder cancer","volume":"69","author":"Crispen","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.surg.2024.10.017_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241234798","article-title":"Elevated INHBA promotes tumor progression of cervical cancer","volume":"23","author":"Wu","year":"2024","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.surg.2024.10.017_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41419-022-04720-0","article-title":"CircTHBS1 drives gastric cancer progression by increasing INHBA mRNA expression and stability in a ceRNA- and RBP-dependent manner","volume":"13","author":"Qiu","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.surg.2024.10.017_bib27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3892\/or.2016.5290","article-title":"MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma","volume":"37","author":"Zhou","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.surg.2024.10.017_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biopha.2015.07.012","article-title":"Effect of RTKN on progression and metastasis of colon cancer in\u00a0vitro","volume":"74","author":"Qu","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.surg.2024.10.017_bib29","first-page":"1461","article-title":"miR-145 inhibits breast cancer cell growth through RTKN","volume":"34","author":"Wang","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00432-004-0638-8","article-title":"Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients","volume":"131","author":"Fan","year":"2005","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.surg.2024.10.017_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11033-022-07978-x","article-title":"HYOU1 promotes cell proliferation, migration, and invasion via the PI3K\/AKT\/FOXO1 feedback loop in bladder cancer","volume":"50","author":"Wang","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.surg.2024.10.017_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12967-024-05517-9","article-title":"Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer","volume":"22","author":"Papulino","year":"2024","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.surg.2024.10.017_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/0008-5472.CAN-23-0966","article-title":"FASN inhibition decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular carcinoma","volume":"84","author":"Huang","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2024.10.017_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113404","article-title":"A\u00a0perspective on cell therapy and cancer vaccine in biliary tract cancers (BTCs)","volume":"12","author":"Han","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2024.10.017_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051181","article-title":"Immunotherapy in bladder cancer: current methods and future perspectives","volume":"12","author":"Wolacewicz","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.surg.2024.10.017_bib36","article-title":"Oxidative stress is a concept, not an indication for selective antioxidant treatment","volume":"12","author":"Lichtenberg","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.surg.2024.10.017_bib37","article-title":"Molecular mechanisms of oxidative stress in stroke and cancer","volume":"5","author":"Chavda","year":"2022","journal-title":"Brain Disord"},{"key":"10.1016\/j.surg.2024.10.017_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1225578","article-title":"ROS: basic concepts, sources, cellular signaling, and its implications in aging pathways","volume":"2022","author":"de Almeida","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.surg.2024.10.017_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166393","article-title":"Oxidative stress and endogenous DNA damage in blood mononuclear cells may predict anti-SARS-CoV-2 antibody titers after vaccination in older adults","volume":"1868","author":"Ntouros","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.surg.2024.10.017_bib40","article-title":"Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine","volume":"14","author":"Sun","year":"2023","journal-title":"Front Immunol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606024009024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606024009024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:51:40Z","timestamp":1736286700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606024009024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":40,"alternative-id":["S0039606024009024"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2024.10.017","relation":{},"ISSN":["0039-6060"],"issn-type":[{"type":"print","value":"0039-6060"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of tumor-antigen signatures and immune subtypes for mRNA vaccine selection in muscle-invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2024.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108926"}}